360
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Angiogenesis-related gene expression analysis in celiac disease

, , , , , , , & show all
Pages 264-270 | Received 26 Apr 2011, Accepted 31 Oct 2011, Published online: 09 Jan 2012

References

  • Stepniak D, Koning F. Celiac disease–sandwiched between innate and adaptive immunity. Hum Immunol. 2006; 67:460–468.
  • van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol. 2005; 19:323–339.
  • Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol. 2009; 9 12: 858–870.
  • Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci. 2002; 27 10: 534–539.
  • Caja S, Myrsky E, Korponay-Szabo IR, Nadalutti C, Sulic AM, . Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies. Scand J Gastroenterol. 2010; 45 4: 421–427.
  • Castellanos-Rubio A, Martin-Pagola A, Santín I, Hualde I, Aransay AM, Castaño L, . Combined functional and positional gene information for the identification of susceptibility variants in celiac disease. Gastroenterology. 2008; 134 3: 738–746.
  • Castellanos-Rubio A, Santin I, Martin-Pagola A, Irastorza I, Castaño L, Vitoria JC, . Long-term and acute effects of gliadin on small intestine of patients on potentially pathogenic networks in celiac disease. Autoimmunity. 2010; 43 2: 131–139.
  • Myrsky E, Caja S, Simon-Vecsei Z, Korponay-Szabo IR, Nadalutti C, Collighan R, . Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA. Cell Mol Life Sci. 2009; 66 20: 3375–3385.
  • Myrsky E, Syrjänen M, Korponay-Szabo IR, Mäki M, Kaukinen K, Lindfors K. Altered small-bowel mucosal vascular network in untreated coeliac disease. Scand J Gastroenterol. 2009; 44 2: 162–167.
  • Halttunen T, Marttinen A, Rantala I, Kainulainen H, Mäki M. Fibroblasts and transforming growth factor beta induce organization and differentiation of T84 human epithelial cells. Gastroenterology. 1996; 111 5: 1252–1262.
  • Martin-Pagola A, Ortiz L, Perez de Nanclares G, Vitoria JC, Castaño L, Bilbao JR. Analysis of the expression of MICA in small intestinal mucosa of patients with celiac disease. J Clin Immunol. 2003; 23 6: 498–503.
  • van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, . A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet. 2007; 39 7: 827–829.
  • Ruckhäberle E, Karn T, Engels K, Turley H, Hanker L, Müller V, . Prognostic impact of thymidine phosphorylase expression in breast cancer comparison of microarray and immunohistochemical data. Eur J Cancer. 2010; 46 3: 549–557.
  • Xiao Y, Motomura S, Podack ER. APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response. Eur J Immunol. 2008; 38 12: 3450–3458.
  • Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev. 2008; 7 8: 644–650.
  • Castellanos-Rubio A, Santin I, Irastorza I, Castaño L, Vitoria JC, Bilbao JR. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity. 2009; 42 1: 69–73.
  • Vannay A, Sziksz E, Prókai A, Veres G, Molnár K, Szakál DN, . Increased expression of hypoxia-inducible factor 1alpha in coeliac disease. Pediatr Res. 2010; 68 2: 118–122.
  • Park SY, Jung MY, Lee SJ, Kang KB, Gratchev A, Riabov V, . Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J Cell Sci. 2009; 122 18: 3365–3373.
  • Jones RA, Kotsakis P, Johnson TS, Chau DY, Ali S, Melino G, . Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ. 2006; 13 9: 1442–1453.
  • Grötzinger T, Sternsdorf T, Jensen K, Will H. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem. 1996; 238 2: 554–560.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.